基于抗性恢复的高效克隆超短片段重组质粒的构建

分子克隆作为一种常规技术被广泛应用于DNA及蛋白质的研究。在传统的分子克隆中,主要通过限制性内切酶先分别消化目的 DNA片段及载体,再纯化回收,然后用DNA连接酶将二者连接。而对一些超短基因片段(300 bp),通过酶切及切胶纯化后,回收率极低,导致插入表达载体比较困难。文中介绍了一种新的利用质粒抗性恢复进行克隆的方法,大大提高了克隆效率,为短基因片段的分子克隆提供了一种高效的方法。     

一种简单有效的克隆未知旁侧DNA片段的方法

操作含长插入片段的DNA克隆时 ,经常需要进行亚克隆和测序实验。通常的方法首先是得到插入片段的限制性内切酶谱 ,然后选择合适的内切酶消化DNA ,分离靶片段 ,将其连接入质粒载体中进行下一步操作。但这种方法工作量大 ,步骤繁琐。在此 ,介绍一种不需要做限制性内切酶谱分析 ,而根据靶片段的旁侧序列直接进行亚克隆实验的方法。首先 ,选择合适的限制性内切酶消化含长插入片段的DNA克隆 ,其中一种酶切在已知的旁侧序列上 ,另一为随机选择 ;然后酶切混合物与线性化的质粒载体连接 ,转化细菌得到一“亚克隆库” ;将其中的克隆挑选入 96孔板培养后 ,按行或列混合菌液得到相应的“pool” ;最后 ,用PCR方法筛选获得含靶DNA片段的阳性克隆 ,其中所用的引物一个与已知的旁侧DNA序列配对 ,另一个与质粒载体上序列配对 ,PCR扩增已知的旁侧DNA片段以鉴定阳性克隆。多次独立实验表明该方法简单有效 ,可广泛用于亚克隆和DNA步移实验     

在枯草杆菌中有启动子功能的噬菌体T5 DNA片段的克隆

用启动子探针质粒pTG 402为载体,用鸟枪射击法克隆了噬菌体T5 DNA的片段。克隆中的2％含有具启动子功能的插入片段,其中pTG 402-20含有启动功能最强的插入片段。DNA-DNA分子杂交实验结果表明,pTG 402-20的插入片段能与T5 DNA Hind Ⅲ酶切的G和B片段杂交。这个插入片段的大小约为0.84kb。     

扣囊拟内孢霉α-淀粉酶基因的克隆和在酿酒酵母中表达

以穿梭质粒pCN60为载体,大肠杆菌C600为受体构建了扣囊拟内孢霉(Endomycopsis fibuligera)G45 Sau 3A基因文库。从基因文库中提取重组质粒DNA并转化酿酒酵母(Saccharomyces cerevisiae)BJ1991,选出四个具有o-淀粉酶活性的转化子,琼脂糖凝胶电泳结果证实插入的DNA片段为9.0kb。对插入DNA片段亚克隆,确定。-淀粉酶基因位于PstI-Sall 3.9kb片段上,启动子位于PstI-EcoRI 的1.3kb片段上。用亚克隆PGK11.9kb片段置换。-淀粉酶启动子区,其转化子的e-淀粉酶活性有明显提高。     

菠菜叶绿体DNA 4.1 kb的SalⅠ片段的克隆

利用pBR 322衍生质粒DNA为载体,将菠菜叶绿体DNA的SalⅠ限制性片段插入质粒的Sal Ⅰ位点,获得52个含重组质粒的菌落(Ap~rTc~5)。并对每个克隆的质粒进行限制性内切酶分析,通过Southern吸印与探针杂交,证明了重组质粒pSS104含有的插入DNA是菠菜叶绿体DNA 4.1kb的SalⅠ片段。迄今在该片段尚未定位任何已知的叶绿体基因,用大肠杆菌的活体系统也未能发现这段DNA的转录产物,本文对此进行了讨论。     

耐甲氧西林葡萄球菌PBP2a的质粒克隆与构建

目的克隆并构建耐甲氧西林金黄色葡萄球菌（MRSA）青霉素结合蛋白2a（PBP2a）全长及转肽酶区的原核表达质粒。方法登录基因文库查找获得mecA基因的编码序列,应用PCR技术扩增获得DNA片段,将此基因片段插入PET-32a载体,同时酶切鉴定阳性克隆,DNA序列测定验证序列正确性。结果 PCR扩增获得了mecA基因全长及转肽酶区DNA片段,成功插入到原核表达载体PET32a,双酶切鉴定及DNA序列测定证实插入片段正确。结论成功构建了PBP2a全长及转肽酶区片段表达质粒,为该蛋白的纯化表达和疫苗研究奠定了基础。     

扣囊拟内孢霉α-淀粉酶基因的克隆和在酿酒酵母中表达

以穿梭质粒pCN60为载体,大肠杆菌C600为受体构建了扣囊拟内孢霉(Endomycopsis fibuligera)G45 Sau 3A基因文库。从基因文库中提取重组质粒DNA并转化酿酒酵母(Saccharomyces cerevisiae)BJ1991,选出四个具有o-淀粉酶活性的转化子,琼脂糖凝胶电泳结果证实插入的DNA片段为9.0kb。对插入DNA片段亚克隆,确定。-淀粉酶基因位于PstI-Sall 3.9kb片段上,启动子位于PstI-EcoRI 的1.3kb片段上。用亚克隆PGK11.9kb片段置换。-淀粉酶启动子区,其转化子的e-淀粉酶活性有明显提高。     

人snail真核表达载体构建与鉴定

目的:构建人snail基因真核表达载体并鉴定。方法:使用RT-PCR法获取人snail基因全长c DNA,经Bam H I、Eco R I双酶切、连接,插入pc DNA3.1(+)真核表达载体,转化TOP10感受态细胞,用含氨苄青霉素的LB培养基筛选阳性克隆,提取质粒双酶切电泳及测序鉴定,瞬时转染siha细胞Western-blot从蛋白水平鉴定重组质粒在真核细胞内的表达。结果:pc DNA3.1-snail重组质粒经酶切电泳符合预期片段,测序鉴定插入片段与NCBI Gen Bank文库中人snail序列一致,重组质粒瞬时转染后snail蛋白表达量明显增高。结论:成功构建pc DNA3.1-snail重组质粒载体,为进一步探讨snail基因生物学功能奠定了基础。     

大肠杆菌质粒DNA提取方法的优化

目的:简化操作流程,缩短提取时间,降低试验对操作者的危害。方法:该方法去除酚、氯仿等有害试剂,采用LiCl沉淀去除质粒制备物中小片段核酸(包括DNA和RNA);工程菌生长至对数期时通过加入氯霉素后不仅方便质粒DNA的提取过程中蛋白质的去除,而且可使质粒的拷贝数进一步增加,提高质粒DNA产量的目的。结果:实验改进方法所提取的质粒DNA产量高于常规方法,达到20μg/mL。结论:改进方法提取的质粒DNA,其下游的内切酶消化,PCR、重组质粒鉴定、转化大肠杆菌等实验的结果和重复性都令人满意,完全可用于一般的分子生物学研究。     

含G0S2基因启动子的荧光素酶报告基因载体的构建

目的:克隆人G0S2基因启动子并构建荧光素酶报告基因载体,为进一步研究G0S2基因转录调控提供质粒。方法:利用PCR技术从人胚肾293A细胞基因组DNA中克隆获得G0S2基因启动子的DNA片段,将其克隆至pGL3-basic表达载体中,并转化人大肠杆菌DH5α,经限制性内切酶酶切、PCR及测序鉴定得到确认;将重组载体质粒与半乳糖苷酶表达质粒psV-β-Galactosidase共转染至大鼠血管平滑肌细胞(VSMC),检测细胞中荧光素酶的活性。结果:pGL3-G0S2-Promoter重组质粒插入片段和相邻序列正确,克隆的G0S2基因片段有启动子活性(P0.05)。结论:成功构建了pGL3-G0S2-Promoter报告基因质粒,为进一步研究G0S2基因的表达奠定了基础。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).